In this study CLDN1 is elevated in serous EOC and sufficient to cluster ovarian tumor types, which suggests it, by itself, is an ovarian cancer-type biomarker but not a prognostic biomarker. The gene discussed is CLDN1; the disease is ovarian cancer.